(E)-4-Fluorophenethyl 3-(3-hydroxy-4-(methylsulfonyl)phenyl)acrylate, 10mg

(E)-Hex-1-en-1-ylboronic acid, 95.0%, 5g

1-Benzylpiperidine-3,5-dione, 95.0%, 5g

Ethyl 1H-pyrrolo[3,4-c]pyridine-2(3H)-carboxylate, 95.0%, 1g

m-xilene, minimo 98,5%, per sintesi, 2,5 l, confezione in vetro

4-Bromo-2-(2,6-dioxopiperidin-3-yl)-5-fluoroisoindoline-1,3-dione, 100mg

4-Amino-2-methylbenzamide, 98+%, 5g

2-Ethyl-1-butanol>98.0%(GC)25mL

3-Bromo-2-chloro-5-(trifluoromethoxy)pyridine, 97.0%, 50mg

2-Amino-9,9-diphenylfluorene>98.0%(HPLC)(T)5g

3-FLUORO-5-(METHOXYCARBONYL)-2-METHYLPHENYLBORONIC ACID, 95.0%, 1g

2-(3-(4-Bromo-2-fluorobenzyl)-4-oxo-3,4-dihydrophthalazin-1-yl)acetic acid, 97%, 10mg

2-Methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid, 98%, 5g